GLP-1 Medication Recalls — Complete History
If you are exploring fda-news, this comprehensive resource breaks down the latest evidence, practical tips, and expert insights to help you make informed decisions about your health journey.
Regulatory Timeline
The timeline of regulatory warnings about GLP-1 medications reveals a series of events that lawyers assert proves the companies were aware of dangerous side effects before they were added to drug labels.
Key regulatory milestones include:
- 2017: Ozempic FDA approval for type 2 diabetes
- 2021: Wegovy FDA approval
- 2022: Mounjaro FDA approval
- 2023-2024: Mounting adverse event reports
- 2024: JAMA study on NAION risk
- 2024-2025: Warning changes acknowledging serious adverse event disclosures
- 2025-2026: Consolidated litigation begins
Why This Matters for Your Case
FDA warning history serves as key documentation because it may show:
- What the manufacturer knew and how long they had the information
- Whether warnings were adequate — were patients and doctors accurately communicate the dangers
- Delayed disclosure — any gaps between company awareness and label updates
- Regulatory pressure — whether the FDA had to force warning updates
This information supports the primary legal theory in the Ozempic litigation: that Novo Nordisk and Eli Lilly chose revenue over patient welfare.
Think you may have a case? Get a free, confidential case evaluation from an experienced GLP-1 litigation attorney.
This information is for educational purposes only and does not constitute legal advice. Past results do not guarantee future outcomes.
Frequently Asked Questions
Where can I find additional resources on fda-news?
Trusted resources are reputable health organizations like the Mayo Clinic and the Endocrine Society. Make a point to confirm information with your doctor.
Are there risks related to fda-news?
Similar to all treatment-related decisions, there are factors that deserve attention. Talk about your worries with a qualified provider to get personalized guidance.
What should I bring up with my healthcare provider about fda-news?
Begin with bringing up the relevance to your personal medical history. Your doctor can tailor advice accounting for your health history and other treatments you are taking.